Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1992 | 12-1991 | 12-1990 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,135 | 10,873 | 1,284 | 3,164 | 3,164 |
| Marketable Securities | 5,279 | 5,279 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 12 | 35 | 35 |
| Other current assets | 279 | -5,034 | 209 | 82 | 82 |
| TOTAL | $11,693 | $11,118 | $1,505 | $3,281 | $3,281 |
| Non-Current Assets | |||||
| PPE Net | 1,363 | 1,363 | 2,108 | 297 | 297 |
| TOTAL | $1,363 | $1,363 | $2,108 | $297 | $297 |
| Total Assets | $13,056 | $12,803 | $3,613 | $3,578 | $3,578 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 29 | N/A | 43 | 38 | 38 |
| Accounts payable and accrued liabilities | 210 | 478 | 768 | 404 | 404 |
| Accrued Expenses | 649 | N/A | 0 | 0 | 0 |
| Other current liabilities | 0 | N/A | 18 | 34 | 34 |
| TOTAL | $1,129 | $754 | $1,091 | $476 | $476 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19 | 573 | 108 | 151 | 151 |
| TOTAL | $600 | $573 | $988 | $151 | $151 |
| Total Liabilities | $1,729 | $1,627 | $2,079 | $627 | $627 |
| Shareholders' Equity | |||||
| Common Shares | 95 | 95 | 34 | 26 | 26 |
| Retained earnings | -30,067 | N/A | -9,357 | -5,306 | -5,306 |
| Other shareholders' equity | 0 | 11,081 | 2,621 | 2,951 | 2,951 |
| TOTAL | $11,327 | $11,176 | $1,534 | $2,951 | $2,951 |
| Total Liabilities And Equity | $13,056 | $12,803 | $3,613 | $3,578 | $3,578 |